Výsledky vyhledávání - "R. N. Zarate"

1095 Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

Autor: Jesús García-Foncillas, Eva Bandrés, N. Bitarte, M. Ponz, J.A. Diaz-Gonzalez, Javier Rodríguez, R. N. Zarate, Natalia Ramírez, A. Chopitea, A. Hernandez

Publikováno v: European Journal of Cancer Supplements. 7:113

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::723429cd4bd491784cc77aa284ec6fdf
https://doi.org/10.1016/s1359-6349(09)70388-x

Zobrazit plný text záznamu

Predictive value of Ile105Val polymorphism of the gluthatione-S-transferase P1 in patients with metastatic colorectal cancer (m CRC) treated with the triplet combination of irinotecan, oxaliplatin, and capecitabine

Autor: Ana Chopitea, Eva Bandrés, J. Rodriguez, Mariano Ponz, R. N. Zarate, Nerea Bitarte, Natalia Ramírez, Antonio Viudez, Jesús García-Foncillas

Publikováno v: ResearcherID

2544 Background: Several phase I/II trials have shown that the triplet combination of oxaliplatin, irinotecan and capecitabine is a feasible and active in solid tumors. We aimed to investigate whether germline polymorphisms may be predictors of clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcccfc276a12c987b06d1a3edaa715dd
https://doi.org/10.1200/jco.2009.27.15_suppl.2544

Zobrazit plný text záznamu

501 POSTER Expression of microRNA-451 is associated with disease-free survival in gastric cancer patients treated with chemoradiotherapy after gastric resection

Autor: Xabier Agirre, N. Bitarte, Natalia Ramírez, Javier Rodríguez, Eva Bandrés, R. N. Zarate, Fernando Arias, J.J. Sola, Jesús García-Foncillas

Publikováno v: European Journal of Cancer Supplements. 5:90

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f75241d4f8303aea09b793684cfa0730
https://doi.org/10.1016/s1359-6349(07)70440-8

Zobrazit plný text záznamu

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy

Autor: R. N. Zarate, Jesús García-Foncillas, Raquel Malumbres, Fernando Arias, Elena Cubedo, Eva Bandrés

Publikováno v: World Journal of Gastroenterology. 12:6032

AIM: To evaluate the potential association of xeroderma pigmentosum group D (XPD) codon 751 variant with outcome after chemo-radiotherapy in patients with resected gastric cancer. METHODS: We used PCR-RFLP to evaluate the genetic XPD Lys751Gln polymo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03403a218c007ed5c986afa9ec953f2
https://doi.org/10.3748/wjg.v12.i37.6032

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání